Results 21 to 30 of about 17,525 (157)

Role of ubiquitination in IGF-1 receptor signaling and degradation. [PDF]

open access: yesPLoS ONE, 2007
BACKGROUND: The insulin-like growth factor 1 receptor (IGF-1R) plays numerous crucial roles in cancer biology. The majority of knowledge on IGF-1R signaling is concerned with its role in the activation of the canonical phosphatidyl inositol-3 kinase ...
Bita Sehat   +4 more
doaj   +1 more source

Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells. [PDF]

open access: yesPLoS ONE, 2012
Type I insulin-like growth factor receptor (IGF-1R) and insulin receptor (INSR) are highly homologous molecules, which can heterodimerize to form an IGF-1R/INSR hybrid (Hybrid-R).
Yu-Chieh Wu   +2 more
doaj   +1 more source

Controlled Signaling—Insulin-Like Growth Factor Receptor Endocytosis and Presence at Intracellular Compartments

open access: yesFrontiers in Endocrinology, 2021
Ligand-induced activation of the IGF-1 receptor triggers plasma-membrane-derived signal transduction but also triggers receptor endocytosis, which was previously thought to limit signaling.
Leonie Rieger, Rosemary O’Connor
doaj   +1 more source

Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma. [PDF]

open access: yesPLoS ONE, 2014
The interaction between the tumor cells in classical Hodgkin lymphoma (cHL) and the microenvironment includes aberrant activity of receptor tyrosine kinases.
Zheng Liang   +6 more
doaj   +1 more source

Endothelium–gut communication: IGF‐1Rs crosstalk with microbiota

open access: yesEMBO reports, 2021
The gut, with its extensive microbiota, plays a fundamental role in metabolism. While alterations of the gut microbiota can induce dysfunction of the endothelium, it remains unclear whether the endothelium can directly impact the gut microbiota. To answer this question, in this issue of EMBO Reports Haywood and colleagues deployed a murine model with ...
Zhen Bouman Chen, Naseeb Kaur Malhi
openaire   +2 more sources

Insulin-like growth factor 1 receptor mediates photoreceptor neuroprotection

open access: yesCell Death and Disease, 2022
Insulin-like growth factor I (IGF-1) is a neurotrophic factor and is the ligand for insulin-like growth factor 1 receptor (IGF-1R). Reduced expression of IGF-1 has been reported to cause deafness, mental retardation, postnatal growth failure, and ...
Ammaji Rajala   +6 more
doaj   +1 more source

Deficiency of insulin-like growth factor-1 receptor confers resistance to oxidative stress in C2C12 myoblasts. [PDF]

open access: yesPLoS ONE, 2013
IGF-1 receptor (IGF-1R) signaling regulates cell growth, transformation and survival. Haploinsufficiency of the IGF-1R is reported to paradoxically confer resistance to oxidative stress in vivo and in cells cultured from Igf1r(+/-) mice.
Sachin Thakur, Neha Garg, Martin L Adamo
doaj   +1 more source

Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury

open access: yesRespiratory Research, 2005
Background Cellular responses to aging and oxidative stress are regulated by type 1 insulin-like growth factor receptor (IGF-1R). Oxidant injury, which is implicated in the pathophysiology of a number of respiratory diseases, acutely upregulates IGF-1R ...
Flejou Jean-François   +7 more
doaj   +1 more source

The Role of IGF-1R in Pediatric Malignancies [PDF]

open access: yesThe Oncologist, 2009
Learning Objectives Evaluate the components that make up the insulin-like growth factor family. Differentiate between different strategies to modulate IGF-1R. Determine when to utilize the rationale for therapeutic targeting of IGF-1R in childhood malignancies.
Su Young, Kim   +3 more
openaire   +2 more sources

Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody

open access: yesHaematologica, 2010
Background Alterations in the PI3K/Akt pathway are found in a wide range of cancers and the development of PI3K inhibitors represents a promising approach to cancer therapy.
Nicolas Chapuis   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy